Abstract. Gicerin, an Ig-superfamily cell adhesion molecule, has homophilic adhesion activity, thus leading to the formation of gicerin aggregates. Gicerin is highly expressed in various embryonic tissues, and it contributes to development through its adhesive activities. In contrast, the expression of the protein is limited to the muscular tissues and endothelial cells in the mature animals. In the liver, gicerin is constitutively expressed in sinusoidal endothelial cells. Interestingly, an overexpression of gicerin is found in a variety of tumors and may play a role in tumorigenesis. Previously, up-regulated expression of the gicerin protein was found in some sporadic cases of chicken colorectal adenocarcinomas and their hepatic metastasized lesions. In the present study, gicerin cDNA was introduced into endogenous gicerin negative ACL-15 cells, a rat colon adenocarcinoma cell line. The cells were subsequently evaluated for changes in their metastatic potentials in order to elucidate the possible role of gicerin in the hepatic metastasis of colorectal adenocarcinomas. The stable overexpression of gicerin in the cells enhanced the self-aggregation and migratory activities on the protein compared with the mock-transfectants. In addition, the gicerintransfectants had enhanced metastatic potential to the liver compared with mock-transfected cells after implantation into the ileocolic vein of the cognate rats. These results suggest that gicerin might promote the interaction of tumor cells with a hepatic endothelium, thus leading to the hepatic metastasis of colon adenocarcinomas.
Introduction
Gicerin is an immunoglobulin-superfamily cell adhesion molecule (CAM) purified from chicken smooth muscle as a neurite promote factor (1) . The genomic sequence of gicerin is highly homologous with B-CAM, BEN/DM-GRASP/SC1, HEMCAM and CD146/MelCAM (2) (3) (4) . Gicerin contains five Ig-like domain structures in the extracellular region. Each domain is rendered stable by a disulfide cross-link between two ß-pleated sheets. The cytoplasmic domain is relatively short and it possesses potential recognition sites for protein kinases, although direct evidence of phosphorylation of these sites is still lacking. Chicken gicerin exhibits homophilic cell adhesion activity, in addition to the heterotypic adhesion to neurite outgrowth factor (NOF), a laminin-like molecule (5-7). However, this heterophilic binding activity of gicerin has not been observed in other animals. Gicerin appears in numerous embryonic tissues, including the nervous system, kidneys, and respiratory system, and seems to play a role in cell migration, neurite extension, epithelialization and cell condensation through its cell adhesive activity (8) . Gicerin is almost completely absent from most adult tissues, and its expression is restricted to muscles and endothelial cells in blood vessels. Interestingly, we found gicerin to be overexpressed in some sporadic tumors of animals, including Wilm's tumor, oviductal adenocarcinomas, lymphatic sarcomas, melanoma, and mammary gland adenocarcinomas (9) (10) (11) (12) . In addition, we also previously showed gicerin transfection to promote the formation of gicerin aggregates, while increasing both migration and metastasis, as determined by in vitro analyses and cell implantation experiments using animals (11, 13) .
Colorectal carcinomas are a suitable tumor to elucidate the potential function of gicerin on cancer metastasis with respect to the tumor-endothelial interactions for several reasons. First, colorectal carcinoma is a highly metastatic malignancy, and metastasizes most frequently to the liver through the portal vein. Second, several sporadic cases of colorectal carcinoma have been reported in animals, and the hepatic metastases of these tumors were enriched in gicerin ONCOLOGY REPORTS 24: 1427 -1431 , 2010 Involvement of gicerin, a cell adhesion molecule, in the portal metastasis of rat colorectal adenocarcinoma cells KAZUHIDE ADACHI 1 , MAHIRO HATTORI in our preliminary study. Finally, hepatic sinusoidal endothelial cells constitutively express gicerin on its cell surface. We hypothesized that the introduction of the gicerin gene into gicerin-negative cells, and the subsequent analysis of their metastatic potential in the liver may thus provide a useful model for elucidating the possible role of gicerin in hepatic metastasis. In the present study, we established gicerin-transfected ACL cells, a transplantable cell line derived from a rat colorectal adenocarcinoma, and then examined the hepatic metastasis of these and control cells following implantation into the portal vein. Protein extractions and Western blotting. The transfected cells grown in DMEM were detached from the culture dish with a rubber scraper and then were centrifuged at 3,000 rpm for 10 min. The collected cells were homogenized in PBS and centrifuged at 15,000 rpm for 15 min. The pellet was solubilized by incubation in 10 mM Tris/acetate (pH 8.0), 0.5 mM EDTA, 0.5% Nonidet P-40 at room temperature for 1.5 h on a rotating shaker, then centrifuged at 15,000 rpm for 20 min. The resulting supernatants were used for Western blot experiments. Equal volume of the supernatants was separated using 7.5% SDS-PAGE and electrotransferred to polyvinyl difluoride membranes (Bio-Rad). The blots were blocked with 3% skim-milk in PBS containing 0.05% Tween-20 (PBST) for 1 h at 37˚C and then incubated with a primary antibody against gicerin diluted in PBST with 3% skim-milk for 1 h at 37˚C. After washing the membranes with PBST three times, they were incubated with the secondary antibody in PBST with 3% skim milk for 1 h at 37˚C. Next, the membranes were washed three times in PBST and washed in PBS, and the blots were visualized on X-ray film using ECL solution (Gibco) (14) .
Materials and methods

Establishment
Immunocytochemistry. Each of the transfected cell lines was grown on the cover slips to semiconfluency and then was fixed in Zamboni's fixative solution. The cover slips were washed twice with PBS and incubated with the polyclonal rabbit antibody against gicerin for 1 h at 37˚C (13) . After being washed twice with PBS, the cover slips were incubated with fluorescein isothiocyanate-conjugated goat anti-rabbit immunoglobulins (Dako) for 1 h at 37˚C. After being washed with PBS, the cover slips were examined under a fluorescent microscope.
Cell-aggregation assay. The monolayer cultures of parental cells and each of the transfected cell lines were digested with a solution of 0.05% trypsin and 0.01% EDTA and collected by centrifugation at 800 x g, and then re-suspended in DMEM at 6x10 6 cells/ml. Cell suspension (1 ml) was incubated in a round-bottomed polystyrene tube at 37˚C. After a 30-min incubation, the tubes were inverted once and a sample of 50 μl was removed and observed under a microscope. To quantify aggregation, the number of cells present as single cells and in clusters (> 4 cells) was counted (at least 100 cells counted in total). The degree of cell aggregation was indicated by the index N 30 /N 0 , where N 0 is the total cell number including aggregated clusters and N 30 is only the aggregated cell cluster number. The experiment was performed five times, the scores were averaged, and then the standard deviations were calculated.
In vitro cell-migration assay. Polyvinylpyrrolidone-free polycarbonate filters (5-μm pore size) were coated with gicerin protein (50 ng/ml) and placed in modified Boydenchambers (Gibco) (12) . A 200-μl aliquot of parental cells, mock-or gicerin-transfected cells (2.0x10 6 cells/ml) was placed in the upper compartment of the Boyden-chambers. DMEM was placed in the lower compartment. After 8 h of incubation at 37˚C, the number of cells that had migrated into the lower compartment were counted under a microscope. The scores were averaged, and then the standard deviations were calculated.
Implantation of gicerin-transfected cells into the rat portal vein.
The gicerin and mock-transfected cells (suspensions of 1.4x10 6 cells in 1 ml DMEM) were injected into the ileocolic vein of adult male F344 rats (five animals for each transfected cell line). Gicerin transfectanted cells incubated with an anti-gicerin polyclonal antibody (400 μg/ml) for 2 h were also injected into the rats as a control. After 10 days, the rats were sacrificed under deep anesthesia with pentobarbital solution, and the lungs, liver, spleen and kidneys were removed and fixed with Zamboni's solution. The paraffin-embedded samples were cut into 3-μm slices with a microtome, and stained with hematoxylin and eosin. The sections were then observed under a light microscope. The number of metastatic foci in the medial lobe of the liver was counted per mm 2 . The score were averaged in each of the rats injected with parental, mock-and gicerin-transfected cells, and standard deviations were calculated. The experiments were all approved by the animal care committee of Osaka Prefecture University.
Results
Cell aggregation and migration activities of gicerintransfected ACL-15 cells.
The expression of gicerin in the ACL cells was examined by immunocytochemical and Western blot analyses using an anti-gicerin polyclonal antibody. This antibody detected bands of around 90 kDa in the membrane fractions of all gicerin-transfected cells (G1, G2 and G3), but not in any of the three mock-transfected cell lines (Fig. 1) . Gicerin was not expressed in either the parental cells or any of the mock-transfected cell lines, but was strongly expressed on the membrane of gicerintransfected cells (Fig. 2) . All of the gicerin-transfected cells stably expressed gicerin on their cell surface even at further passages. Accordingly, we were able to establish ALC-cells that stably express gicerin.
An in vitro cell aggregation assay showed that all gicerin transfectants had enhanced self-aggregation, whereas parental and all of the mock-transfected cells showed only slight aggregation (Fig. 3) . These findings indicate that the gicerin expressed by the transfected cells was functional with respect to the cell-cell interactions.
An in vitro cell migration assay showed a considerable number of the gicerin-transfected cells to migrate into the basement chambers through the pores of filters coated with the gicerin protein. The migration of these cells dramatically increased in comparison to the parental and mock-transfected cells (Fig. 4) . Therefore, gicerin protein promoted the cell migration of gicerin-transfected cells due to their increased homophilic adhesion activity.
Hepatic metastasis of gicerin-transfected cells in F344 rats.
Macroscopic metastasis was not detectable in any organ of rats implanted with any of the three types of cells (data not shown). However, we found that the transfection of gicerin altered the histopathology of the livers. A considerable number ONCOLOGY REPORTS 24: 1427-1431, 2010 and various sizes of hepatic metastatic foci were found in the hepatic tissues after rats were injected with the gicerintransfected cells. Neoplastic tubular or acinar structures developed in the hepatic tissue of these rats (Fig. 5) . The livers from the animals engrafted with parental and mocktransfected cells had only small number of small metastatic lesions, whereas the invasive metastasis was drastically increased in hepatic tissues following an injection with any of the three gicerin-transfected cell lines (Fig. 6) . The antigicerin antibody inhibited the metastatic activity of all gicerintransfected cells. Accordingly, it was clear that the ACL cells obtained their high metastatic potential as a result of gicerin expression on the cell membrane, leading the enhanced portal metastasis. No other organs developed metastasis in any of the rats examined.
Discussion
In the present study, we established gicerin-expressing ACL-15 cells by transfecting gicerin cDNA into the parental ACL-15 cells. The gicerin protein on the surface of the transfected cells was functional in vitro with respect to cellcell binding. In addition, the transfected cells had an increased migratory activity as a result of homophilic (gicerin-gicerin) adhesion. One particularly interesting and potentially important finding in the present study was that gicerin could remarkably enhance the in vivo hepatic metastatic potential of ACL-15 cells. Since there were no obvious differences in doubling times among the established cell lines (data not shown), the enhanced metastasis of gicerin-transfected might have resulted from an increase in cell adhesion and migration, but not from the cell growth.
It is well known that in situ metastasis requires a multistep process characterized by a changing relationship between cancer cells and normal tissues: cancer cells must detach from the primary sites, intravasate through the neighboring cells and/or ECM-networks and then bind to the blood vessels and extravasate into the metastatic site(s) (15) . The loss or dysfunction of E-cadherin is thought to be instrumental in releasing cells from a primary tumor mass byreducing contact-mediated regulation (16) . On the other hand, overexpression of other CAMs encourages the migration of cells through the ECM (17) . Gicerin interacts with itself, as well as with a laminin-like molecule, and probably with other unidentified protein (5) . These adhesive activities of gicerin promote the in vitro migration of embryonic neural cells and primary oviductal cancer cells (4, 13, 18, 19) . In addition, the expression of HEMCAM, which is the same molecule as gicerin, in mouse fibroblasts can down-regulate the maturation of ß-1 integrins and decrease the integrin-dependent cell adhesion of laminin ß-1, fibronectin and vitronectin (20) . These gicerin-mediated cell adhesion activities might result in the enhancement of metastatic activity observed for the ACL-15 cells. Accordingly, the pathway underlying the increase in tumor invasion by gicerin seems to be quite complicated. We believe that gicerin-transfected cells have greater activity with regard to the processes of tumor metastasis, including cells intravasation, embolism and extravasation. In both normal and neoplastic tissues, gicerin is enriched in endothelial cells, and NOF is increased in the basement membrane. These distribution patterns of gicerin and its ligand suggest that gicerin-transfected cells can easily attach to the surface of endothelial cells by gicerin-gicerin binding, allowing the cells to embolize in the vessels. Subsequently, the promotion of cell invasion by gicerin-gicerin and/or gicerin-ECM interactions leads to extravasation through the vessel walls. The interaction of cell adhesion molecules with cytoskeletal elements is involved in a number of cellular functions, such as the ability to form junctions, cell mobility and the mediation of signal transduction (21, 22) . In our other recent studies, gicerin was observed to be expressed on the microvilli of L-929 transfected cells, and it was firmly bound to actin filament through moesin, a member of the ERM family (23) . Thus, the interaction of gicerin with actin filament might increase the mobility of cells.
In conclusion, we herein provided evidence that the expression of gicerin promotes the hepatic metastasis of ACL cells as a result of its increased homophilic adhesive activity. Recently, overexpression of gicerin was found in 10 cases of rat sporadic colorectal cancers: namely, gicerin appeared on the cell surface of cancer cells invading into the muscular layer and metastasizing in the liver. Therefore, gicerin might be involved in the malignant progression of sporadic cases, thereby confirming our observations using these cell lines. We are now examining the expression of gicerin on various types of sporadic tumors in humans, and examining its correlation with the stages of malignancy. We suspect that other molecular events are needed for the acquisition of the fully invasive and metastatic phenotype, although the expression of gicerin on tumor cells contributes to metastasis. Since the natural triggers of such molecular pathways remain unknown, it will be necessary to investigate whether the expression of gicerin is regulated by extracellular factors, such as growth factors and cytokines. The identification of the factors controlling gicerin transcription may thus enable us to inhibit the gicerin-dependent aspects of the malignant progression of cancers.
